Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.75
-2.71 (-15.52%)
At close: Dec 5, 2025, 4:00 PM EST
14.79
+0.04 (0.27%)
After-hours: Dec 5, 2025, 7:58 PM EST
Adaptive Biotechnologies Revenue
Adaptive Biotechnologies had revenue of $93.97M in the quarter ending September 30, 2025, with 102.38% growth. This brings the company's revenue in the last twelve months to $252.75M, up 42.57% year-over-year. In the year 2024, Adaptive Biotechnologies had annual revenue of $178.96M with 5.10% growth.
Revenue (ttm)
$252.75M
Revenue Growth
+42.57%
P/S Ratio
8.77
Revenue / Employee
$408,326
Employees
619
Market Cap
2.25B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ADPT News
- 4 hours ago - Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting - GlobeNewsWire
- 23 hours ago - Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga
- 12 days ago - Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting - GlobeNewsWire
- 4 weeks ago - Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies Corporation (ADPT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha